ArticleMolecular therapy. Methods & clinical development2024

Preclinical specificity & activity of a fully human 41BB-expressing anti-CD19 CART- therapy for treatment-resistant autoimmune disease.

Binghao J Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.